((自动化翻译由路透提供，请见免责声明 ))
11月6日 - ** 合同研究公司查尔斯河实验室 的股价盘前上涨12.36%，至212美元 ；开盘价将创下七周新高
** CRL预计 (link)，调整后每股收益介于10.10美元至10.30美元之间，而此前为9.90美元至10.20美元。
** 公司预计生物技术客户对其药物发现和开发服务的需求将趋于稳定
** 公布第三季度每股收益为 2.59 美元，营业收入为 10 .1 亿美元， 高于LSEG 预测的每股收益为 2.43 美元，营业收入为 9.76 亿美元。
** 21位覆盖CRL的分析师中，有5位将该股评为 "买入 "或更高，13位评为 "持有"，3位评为 "卖出 "或更低；预测中值为205美元。
** 截至上次收盘，该股今年累计下跌约 20
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.